Status: Recruiting
Artesunate Ointment for the Treatment of Anal HSIL in HIV-negative Participants
This is a phase II double blind, placebo-controlled, randomized study of artesunate ointment for the treatment of HIV-negative men and women who have anal high grade squamous intraepithelial lesions (anal HSIL)
Participants needed: 48
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Frantz Viral Therapeutics, LLCUpdated: May 18, 2025Locations: 2
Eligibility criteria
Adult men and women age ≥ 18 years [+10]
Pregnant and nursing women [+7]